ICCS Announces David Allen, Ph.D., is Joining ICCS as Senior Director, Human Health Sciences and Operations

Share

Mail

December 18, 2023

A man wearing glasses and a suit and tie is smiling for the camera.

David Allen, Ph.D., Senior Director, Human Health Sciences and Operations

We are pleased to announce that David Allen, Ph.D., is joining ICCS as Senior Director, Human Health Sciences and Operations. In this new role, he will be responsible for the strategic development and management of the organization’s human health program.

Prior to joining ICCS, Dave was President of Integrated Laboratory Systems, LLC until its acquisition in 2022 by Inotiv, Inc. where he has since served as Vice President of Inotiv, RTP. In addition to his corporate and operational responsibilities, Dave was Principal Investigator of the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) support contract, helping to advance the development and implementation of alternative methods across a wide range of industry and government stakeholders.

Dave has served as President of the American Society for Cellular and Computational Toxicology, President of the Society of Toxicology – In Vitro and Alternative Methods Specialty Section and is the 2017 recipient of the SOT Enhancement of Animal Welfare Award. He received his Ph.D. from North Carolina State University.

Welcome aboard, Dave

< Older Post

Newer Post >

ICCS 2025 Annual Report Now Available: A Year of Global Progress

April 6, 2026

We’re excited to share that the ICCS 2025 Annual Report is now available, highlighting a year of strong momentum driven by the expertise, engagement, and collaboration of our global membership. In 2025, ICCS members across industry, alongside partner organizations and trade and research associations, continued advancing animal-free safety science through practical tools, scientific outputs, and meaningful engagement with the regulatory community. What stands out most is the scale of this collective effort, turning innovation into real-world frameworks and global dialogue that support regulatory progress. Read the full report

International Collaboration on Cosmetics Safety Announces 2026 Board Officers

January 22, 2026

The International Collaboration on Cosmetics Safety (ICCS) today announced the election of its 2026 Board officers, confirmed at the organization’s December 2025 Board meeting. The newly elected leadership reflects ICCS’ continued commitment to advancing approaches in animal-free cosmetics safety.

ICCS Webinar: Applying NAMs in Practice for Skin Sensitization Assessment

January 8, 2026

In July 2025, the International Collaboration on Cosmetics Safety (ICCS) published its Best Practice Guidance (BPG) Document on Skin Sensitization Assessment , supporting the consistent and scientifically robust use of New Approach Methodologies (NAMs). The guidance has been widely welcomed by regulators and safety assessors as a critical step toward strengthening confidence in non-animal approaches for cosmetic ingredient safety evaluation. As regulatory frameworks worldwide continue to advance toward animal-free safety decisions, implementation is the decisive next step. To support this transition, ICCS is convening a free, in-depth webinar focused on how the Guidance can be applied in real-world regulatory risk assessments for skin sensitization. From guidance to practice: This session will demonstrate how defined approaches under OECD Guideline 497— including the 2 out of 3 (2o3), the Integrated Testing Strategy (ITS), and the SARA-ICE model—can be used together within practical, decision-ready risk assessment workflows. Webinar Details Thursday, April 9, 2026 1:00 – 4:30 PM CET Format: Virtual | Free to Attend Speakers and Presentations Donna Macmillan, PhD – Director, Outreach & Capacity Building, ICCS An Introduction to the ICCS Best Practice Guidance Document on Skin Sensitization Petra Kern, PhD – Senior Toxicologist/Risk Assessor, Procter & Gamble A Deep Dive into OECD GL 497 Defined Approaches: 2o3 and ITS Georgia Reynolds, MSc – Safety Science Leader, Unilever Applying OECD GL 497 Defined Approaches: SARA-ICE Nathalie Alépée, PhD – Research Toxicologist & Scientific Officer, L’Oréal The ICCS BPG on Skin Sensitization in Practice: A Case Study The webinar will provide live Q&A, offering attendees the opportunity to engage directly with the speakers and discuss practical, regulatory-relevant questions. Who Should Attend This session is designed for regulatory scientists, safety assessors, and technical experts working across regulatory agencies, industry, and associated research organizations who are involved in skin sensitization assessment and the application of NAM-based evidence. Registration is now open. Register Today Join ICCS and leading experts to explore how NAMs can be confidently applied in regulatory practice and help support robust decision-making without the use of animals.